BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6210936)

  • 1. Coronary vascular responses to vasodilator drugs.
    Goldstein RE
    Prog Cardiovasc Dis; 1982; 24(6):419-36. PubMed ID: 6210936
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
    Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
    N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
    Ghaleh B; Dubois-Randé JL; Hittinger L; Giudicelli JF; Berdeaux A
    Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and reflex effects of nitroglycerin on coronary and left ventricular dynamics in conscious dogs.
    Vatner SF; Higgins CB; Milland RW; Franklin D
    J Clin Invest; 1972 Nov; 51(11):2872-82. PubMed ID: 4404139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism.
    Ihlen H
    Scand J Clin Lab Invest Suppl; 1984; 173():75-9. PubMed ID: 6442005
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced augmentation of coronary flow in vessels with maximum ischemic dilatation.
    Csik V; Szekeres L; Udvary E
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):66-76. PubMed ID: 827991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs.
    Hintze TH; Vatner SF
    Circ Res; 1983 Feb; 52(2 Pt 2):I139-46. PubMed ID: 6403258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action and clinical use of nitroglycerin.
    Horwitz LD
    Postgrad Med; 1973 Apr; 53(4):167-9. PubMed ID: 4632992
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered coronary flow responses to vasoactive drugs in the presence of coronary arterial stenosis in the dog.
    Santamore WP; Walinsky P
    Am J Cardiol; 1980 Feb; 45(2):276-85. PubMed ID: 6766648
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nitroglycerin and dipyridamole on regional coronary resistance.
    Fam WM; McGregor M
    Circ Res; 1968 May; 22(5):649-59. PubMed ID: 4967491
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs.
    Drieu la Rochelle C; Lainée P; Grosset A; O'Connor SE
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):555-63. PubMed ID: 8569215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 and nitroglycerin effects on canine epicardial conductance and distal coronary resistance vessels.
    Miller WL; Bove AA
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):260-7. PubMed ID: 2476600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial blood flow in experimental cardiac hypertrophy in dogs.
    Marchetti GV; Merlo L; Noseda V; Visioli O
    Cardiovasc Res; 1973 Jul; 7(4):519-27. PubMed ID: 4269106
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF; la Rochelle CD; Berdeaux A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracoronary nitroglycerin on lumen diameter during early follow-up angiography after coronary excimer laser atherectomy.
    Baumbach A; Haase KK; Voelker W; Mauser M; Karsch KR
    Eur Heart J; 1991 Jun; 12(6):726-31. PubMed ID: 1907243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of maintaining systemic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease. Effects on coronary blood flow, myocardial energetics and left ventricular function.
    Miller RR; Awan NA; DeMaria AN; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Oct; 40(4):504-8. PubMed ID: 410286
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitroglycerin: new concepts about an old drug.
    Helfant RH
    Am J Med; 1976 May; 60(6):905-9. PubMed ID: 828457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiology of the coronary circulation as a basis for evaluating coronary dilators].
    Lochner W
    Kardiologiia; 1972 Jan; 12(1):22-31. PubMed ID: 4622744
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitroglycerin causes vasodilatation within ischaemic myocardium.
    Gorman MW; Sparks HV
    Cardiovasc Res; 1980 Sep; 14(9):515-21. PubMed ID: 6783307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.